Get the Stockscreener App
4.30
1.24%
0.0528
After Hours:
4.30
Neurometrix Inc stock is traded at $4.30, with a volume of 9,273.
It is up +1.24% in the last 24 hours and up +6.17% over the past month.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
See More
Previous Close:
$4.2472
Open:
$4.485
24h Volume:
9,273
Relative Volume:
0.52
Market Cap:
$8.68M
Revenue:
$5.27M
Net Income/Loss:
$-7.98M
P/E Ratio:
-6.0657
EPS:
-0.7089
Net Cash Flow:
$-7.04M
1W Performance:
-0.92%
1M Performance:
+6.17%
6M Performance:
+8.59%
1Y Performance:
+8.31%
1-Day Range:
$4.24
$4.485
1-Week Range:
$4.13
$4.60
52-Week Range:
$2.66
$4.73
Neurometrix Inc Stock (NURO) Company Profile
Name
Neurometrix Inc
Sector
Industry
Phone
(781) 890-9989
Address
1000 WINTER STREET, WALTHAM
Compare NURO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NURO
Neurometrix Inc
|
4.30 | 8.68M | 5.27M | -7.98M | -7.04M | -0.7089 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Neurometrix Inc Stock (NURO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-17 | Reiterated | H.C. Wainwright | Buy |
| Jun-28-16 | Initiated | Rodman & Renshaw | Buy |
| Sep-11-15 | Initiated | Maxim Group | Buy |
| Feb-27-12 | Initiated | Dawson James | Buy |
Neurometrix Inc Stock (NURO) Latest News
NeuroMetrix Q3 Loss Narrows Y/Y, Quell Sales Drives Growth - MSN
NeuroMetrix (NASDAQ:NURO) Now Covered by Analysts at StockNews.com - Defense World
NeuroMetrix (NASDAQ:NURO) Coverage Initiated at StockNews.com - Defense World
NeuroMetrix revenue down 51% in Q3 2024 - Medical Buyer
NeuroMetrix revenue increases 50% to USD 184,000 in Q3 2024 - Medical Buyer
NeuroMetrix Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.66 loss in 3Q 2023) - Yahoo Finance
NeuroMetrix Q3 2024: Mixed Results Amid Strategic Review - TipRanks
NeuroMetrix Reports Q3 2024 Business Highlights - The Manila Times
NeuroMetrix Q3 Revenue Falls 51% Despite Quell Growth; Cost-Cutting Efforts Show Promise | NURO Stock News - StockTitan
NeuroMetrix (NASDAQ:NURO) Earns Sell Rating from Analysts at StockNews.com - Defense World
NeuroMetrix stock touches 52-week high at $4.73 - Investing.com India
NeuroMetrix stock touches 52-week high at $4.73 By Investing.com - Investing.com UK
StockNews.com Initiates Coverage on NeuroMetrix (NASDAQ:NURO) - Defense World
NeuroMetrix (NASDAQ:NURO) Stock Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Neuromuscular Electrical Muscle Stimulator Industry likely to thriving future growth - Elektrotransports.lv
Transcutaneous Electrical Nerve Muscle Stimulation Industry Size, Status and Business Outlook - Elektrotransports.lv
Interferential Muscle Stimulator Industry Report By Type, Application and Geography - Elektrotransports.lv
Diabetic Neuropathy Market May See a Big Move | Cephalon, GlaxoSmithKline, NeuroMetrix - openPR
NeuroMetrix (NASDAQ:NURO) Now Covered by StockNews.com - Defense World
Financial Analysis: NeuroMetrix (NASDAQ:NURO) versus Sensus Healthcare (NASDAQ:SRTS) - Defense World
NeuroMetrix Inc. | RapidScan | Dec 2006 - Photonics.com
Muscle Stimulator Market Size, Share, Growth Insights - openPR
NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com - Defense World
Internal Neuromodulation Devices Market Size, Trends And Forecast 2024-2033 - WhaTech
One Point One Solutions shares gain as company expands healthcare verticalCheck details - MSN
Rhumbline Advisers Grows Stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World
Kalikesh Singh wins NRAI President election; onus on him to take shooting to next level - RevSportz
Kalikesh Narayan Singh Deo elected NRAI President - IndianShooting.com
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MyChesCo
Mobile-health Network Solutions Receives Nasdaq Delinquency Notice for Minimum Bid Price Requirement - Vancity Buzz
High ROE & high ROCE multibagger stock in focus as company bags pilot export orders worth Rs 2,40,00,000 from clients in Europe, Middle East and USA - Dalal Street Investment Journal
A phone camera as health screening device? Healthtech agency’s new home displays innovations - The Straits Times
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by State of New Jersey Common Pension Fund D - Defense World
Global Electrotherapy System Research Report 2024: A $1.65 Billion Market by 2030 - GlobeNewswire Inc.
Exploring Opportunities in the Muscle Stimulation Devices - openPR
Muscle Stimulator Market Statistical Forecast, Trade Analysis - openPR
NeuroMetrix (STU:NLZ0) Shares Outstanding (EOP) : 2.02 Mil (As of Jun. 2024) - GuruFocus.com
NeuroMetrix (NASDAQ:NURO) Receives New Coverage from Analysts at StockNews.com - Defense World
NeuroMetrix continues strategic review to boost value - Investing.com India
NeuroMetrix stock plunges to 52-week low of $2.66 By Investing.com - Investing.com Canada
NeuroMetrix Reiterates its Review of Strategic Alternatives - StockTitan
NeuroMetrix stock plunges to 52-week low of $2.66 - Investing.com
NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript - Seeking Alpha
NeuroMetrix Second Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.56 loss in 2Q 2023) - Yahoo Finance
Smart Medical Devices Market SWOT and PESTAL Analysis | 2032 - WICZ
Muscle Stimulation Devices Market Detailed Size Estimates - openPR
NURO Stock Earnings: NeuroMetrix Reported Results for Q2 2024 - MSN
NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options - StockTitan
NeuroMetrix reports Q2 revenue $769,148 vs. $1.66M last year - TipRanks
NeuroMetrix (NURO) Scheduled to Post Earnings on Tuesday - Defense World
Neurometrix Inc Stock (NURO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):